RONALD M LINDSAY Insider Trading $SQNM SEQUENOM INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for RONALD M LINDSAY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RONALD M LINDSAY. RONALD M LINDSAY is Director in ARQULE INC ($ARQL) and Director in SEQUENOM INC ($SQNM) and Exec VP, R&D in SEQUENOM INC ($SQNM) and Executive VP, R&D in SEQUENOM INC ($SQNM) and Sr VP, R&D in SEQUENOM INC ($SQNM).
RONALD M LINDSAY in SEQUENOM INC
Trading Symbol: SQNMIndustry: MEASURING & CONTROLLING DEVICES, NEC [3829]
Position of RONALD M LINDSAY: Executive VP, R&D, Exec VP, R&D, Sr VP, R&D, Director
Holdings: 0 shares
Latest Transaction: Sep 07 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of RONALD M LINDSAY in SEQUENOM INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 07 2016 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Director | Option Exercise | D | 0.00 | 5,362 | 0 | 0 | |
Sep 07 2016 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Director | Option Exercise | D | 2.33 | 10,000 | 23,300 | 0 | |
Sep 07 2016 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Director | Option Exercise | D | 1.60 | 31,429 | 50,286 | 0 | |
Sep 07 2016 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Director | Option Exercise | D | 1.11 | 20,000 | 22,200 | 0 | |
Sep 07 2016 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Director | Sell | U | 0.00 | 209,804 | 0 | 0 | 209.8 K to 0 (-100.00 %) |
Jun 16 2016 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Director | Option Exercise | A | 1.11 | 20,000 | 22,200 | 20,000 | |
Feb 11 2016 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Director | Option Exercise | M | 0.00 | 5,362 | 0 | 5,362 | |
Feb 11 2016 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Director | Payment of Exercise | F | 1.66 | 2,025 | 3,362 | 209,804 | 211.8 K to 209.8 K (-0.96 %) |
Feb 11 2016 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Director | Buy | M | 0.00 | 5,362 | 0 | 211,829 | 206.5 K to 211.8 K (+2.60 %) |
Jan 06 2016 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Director | Option Exercise | A | 1.60 | 31,429 | 50,286 | 31,429 | |
Jun 18 2015 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Director | Option Exercise | A | 3.20 | 20,000 | 64,000 | 20,000 | |
Feb 11 2015 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Director | Option Exercise | M | 0.00 | 5,363 | 0 | 10,724 | |
Feb 11 2015 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Director | Buy | M | 0.00 | 5,363 | 0 | 206,467 | 201.1 K to 206.5 K (+2.67 %) |
Jun 11 2014 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Director | Option Exercise | A | 3.07 | 20,000 | 61,400 | 20,000 | |
Feb 12 2014 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Director | Option Exercise | D | 0.00 | 5,363 | 0 | 16,087 | |
Feb 12 2014 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Director | Grant | A | 0.00 | 5,363 | 0 | 201,104 | 195.7 K to 201.1 K (+2.74 %) |
Jan 06 2014 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Director | Option Exercise | A | 2.33 | 10,000 | 23,300 | 10,000 | |
Jun 20 2013 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Executive VP, R&D | Payment of Exercise | F | 4.22 | 9,780 | 41,272 | 194,608 | 204.4 K to 194.6 K (-4.79 %) |
Jun 20 2013 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Executive VP, R&D | Grant | A | 0.00 | 30,000 | 0 | 204,388 | 174.4 K to 204.4 K (+17.20 %) |
Feb 05 2013 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Executive VP, R&D | Option Exercise | A | 0.00 | 21,450 | 0 | 21,450 | |
Feb 05 2013 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Executive VP, R&D | Option Exercise | A | 4.16 | 30,386 | 126,406 | 30,386 | |
Feb 05 2013 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Executive VP, R&D | Option Exercise | A | 4.16 | 12,514 | 52,058 | 12,514 | |
Aug 02 2012 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Exec VP, R&D | Buy | P | 2.87 | 1,900 | 5,453 | 167,243 | 165.3 K to 167.2 K (+1.15 %) |
Aug 02 2012 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Exec VP, R&D | Buy | P | 2.90 | 335 | 972 | 165,343 | 165 K to 165.3 K (+0.20 %) |
Aug 02 2012 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Exec VP, R&D | Buy | P | 2.92 | 1,100 | 3,212 | 165,008 | 163.9 K to 165 K (+0.67 %) |
Aug 02 2012 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Exec VP, R&D | Buy | P | 2.93 | 3,300 | 9,669 | 163,908 | 160.6 K to 163.9 K (+2.05 %) |
Aug 02 2012 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Exec VP, R&D | Buy | P | 2.95 | 2,600 | 7,670 | 160,608 | 158 K to 160.6 K (+1.65 %) |
Aug 02 2012 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Exec VP, R&D | Buy | P | 2.96 | 1,000 | 2,960 | 158,008 | 157 K to 158 K (+0.64 %) |
Aug 02 2012 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Exec VP, R&D | Buy | P | 2.97 | 400 | 1,188 | 157,008 | 156.6 K to 157 K (+0.26 %) |
Aug 02 2012 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Exec VP, R&D | Buy | P | 2.99 | 600 | 1,794 | 156,608 | 156 K to 156.6 K (+0.38 %) |
Aug 02 2012 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Exec VP, R&D | Buy | P | 3.00 | 88,765 | 266,295 | 156,008 | 67.2 K to 156 K (+132.01 %) |
Mar 28 2012 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Exec VP, R&D | Option Exercise | A | 3.93 | 46,875 | 184,219 | 46,875 | |
Mar 28 2012 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Exec VP, R&D | Option Exercise | A | 3.93 | 3,125 | 12,281 | 3,125 | |
Feb 08 2012 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Exec VP, R&D | Option Exercise | A | 4.92 | 68,439 | 336,720 | 68,439 | |
Feb 08 2012 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Exec VP, R&D | Option Exercise | A | 4.92 | 31,561 | 155,280 | 31,561 | |
Feb 08 2012 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Exec VP, R&D | Payment of Exercise | F | 4.92 | 359 | 1,766 | 67,243 | 67.6 K to 67.2 K (-0.53 %) |
Feb 08 2012 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Exec VP, R&D | Grant | A | 0.00 | 1,001 | 0 | 67,602 | 66.6 K to 67.6 K (+1.50 %) |
Feb 08 2012 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Exec VP, R&D | Payment of Exercise | F | 4.92 | 1,436 | 7,065 | 66,601 | 68 K to 66.6 K (-2.11 %) |
Feb 08 2012 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Exec VP, R&D | Grant | A | 0.00 | 4,000 | 0 | 68,037 | 64 K to 68 K (+6.25 %) |
Feb 08 2012 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Exec VP, R&D | Payment of Exercise | F | 4.92 | 1,436 | 7,065 | 64,037 | 65.5 K to 64 K (-2.19 %) |
Feb 08 2012 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Exec VP, R&D | Grant | A | 0.00 | 4,000 | 0 | 65,473 | 61.5 K to 65.5 K (+6.51 %) |
Nov 07 2011 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Exec VP, R&D | Buy | P | 4.24 | 11,200 | 47,488 | 57,950 | 46.8 K to 58 K (+23.96 %) |
Nov 07 2011 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Exec VP, R&D | Buy | P | 4.23 | 8,800 | 37,224 | 46,750 | 38 K to 46.8 K (+23.19 %) |
Nov 03 2011 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Exec VP, R&D | Option Exercise | A | 5.92 | 15,000 | 88,800 | 75,000 | |
Nov 03 2011 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Exec VP, R&D | Option Exercise | A | 5.92 | 60,000 | 355,200 | 60,000 | |
Jul 19 2011 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Exec VP, R&D | Payment of Exercise | F | 7.46 | 1,587 | 11,839 | 36,281 | 37.9 K to 36.3 K (-4.19 %) |
Jul 19 2011 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Exec VP, R&D | Grant | A | 0.00 | 4,999 | 0 | 37,868 | 32.9 K to 37.9 K (+15.21 %) |
Mar 11 2011 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Exec VP, R&D | Buy | P | 5.54 | 20,000 | 110,740 | 32,869 | 12.9 K to 32.9 K (+155.41 %) |
Feb 14 2011 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Exec VP, R&D | Option Exercise | A | 6.70 | 10,417 | 69,794 | 10,417 | |
Feb 14 2011 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Exec VP, R&D | Option Exercise | A | 6.70 | 39,583 | 265,206 | 39,583 | |
Oct 05 2010 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Exec VP, R&D | Option Exercise | A | 6.96 | 47,616 | 331,407 | 47,616 | |
Aug 04 2010 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Sr VP, R&D | Option Exercise | A | 5.92 | 58,109 | 344,005 | 58,109 | |
Aug 04 2010 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Sr VP, R&D | Option Exercise | A | 5.92 | 16,891 | 99,995 | 16,891 | |
May 13 2009 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Director | Option Exercise | A | 3.42 | 20,000 | 68,400 | 20,000 | |
Jun 02 2008 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Director | Option Exercise | A | 7.69 | 20,000 | 153,800 | 20,000 | |
Nov 29 2006 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Director | Buy | P | 4.77 | 5,000 | 23,835 | 5,000 | 0 to 5 K |
Jun 20 2005 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Director | Option Exercise | A | 1.16 | 15,000 | 17,400 | 15,000 | |
May 18 2004 | SQNM | SEQUENOM INC | LINDSAY RONALD M | Director | Option Exercise | A | 1.74 | 15,000 | 26,100 | 15,000 |
Page: 1